BDX
Becton Dickinson
Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: BDX
- Earnings
EPS in 2026 (TTM): $3.95
Last Report Period Date: Mar 31, 2026
According to the most recent financial data from March 2026, the current EPS (TTM) is $3.95. Becton Dickinson's EPS for 2025 came in at $5.83, marking a decrease from $5.88 in 2024. For the quarterly period ending on Mar 31, 2026, BDX's EPS was -$1.11.
BDX earnings history
Becton Dickinson had an annual EPS of $5.83, marking a decrease of 0.9% from $5.88 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was -$1.11, marking a 203.7% decrease from the same quarter last year. BDX's TTM EPS stands at $3.95 as of March 2026. Becton Dickinson's EPS for 2024 stood at $5.88, a 18.3% increase from 2023.
BDX earnings chart
BDX EPS growth history
Over the last 12 months, Becton Dickinson has registered an EPS growth of -203.7% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of -0.6% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 16.2%. A 10-year view shows that BDX has seen an average EPS growth of 5.4% per year.
BDX Earnings Waterfall
BDX Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| RMD Resmed Inc | 18.53 | 37.6% | 21.4% | 17.2% |
| LH Laboratory Corp Of America Holdings | 23.33 | 18.6% | -9.1% | -8% |
| TMO Thermo Fisher Scientific Inc | 26 | 7.2% | 0% | 2% |
| BDX Becton Dickinson & Co | 36.84 | -0.9% | -0.6% | 16.2% |
| BIO Bio-Rad Laboratories Inc | 49.62 | 142.6% | N/A | -26.3% |
| ISRG Intuitive Surgical Inc | 49.83 | 22.3% | 29.1% | 21.5% |
| XRAY DENTSPLY SIRONA Inc | N/A | 33% | N/A | N/A |
| BAX Baxter International Inc | N/A | -47.2% | N/A | N/A |
| TFX Teleflex Inc | N/A | -1,462.4% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -357.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.